Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.42 +0.03 (+8.98%)
As of: Oct 21, 2026 · 3:59 PM EDT

Biodexa Pharmaceuticals (BDRX) Other Non-Current Assets (2018)

Updated

Biodexa Pharmaceuticals' Other Non-Current Assets came in at $18.44 million for the quarter ended Jun 30, 2018.

Analysis

Biodexa Pharmaceuticals (BDRX) Other Non-Current Assets (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.73 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 4.75 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 9.94 Bn
10 Biodexa Pharmaceuticals 4,123.69 -23.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 11.87 Mn
Jun 30, 2018 17.70 Mn
API Access

Biodexa Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY